Petitioner Helsinn Healthcare S.A. (“Helsinn”) owns four patents: U.S. Patent No(s). 7,947,724 (“724 patent”), 7,947,725 (“725 patent”), 7,960,424 (“424 patent”), and 8,598,219 (“219 patent”), which relate to the drug palonosetron used in the treatment...
PATENTS
(LIIBULLETIN preview)
In 1839, Congress passed 35 U.S.C. § 145’s predecessor which set forth the modern framework for reimbursing the United States Patent and Trademark Office (“PTO”) for the expenses it incurs from litigating rejected patent claims. NantKwest, Inc. v....